University of Alberta chemical process licensed to GreenCentre holds promise for greener pharmaceutical production
Advertisement
A green chemical process with the potential to make production of pharmaceutical products more efficient and environmentally friendly has been licensed to GreenCentre Canada from the University of Alberta.
The process, developed by UAlberta chemist Dr. Dennis Hall, uses a novel, heavy-metal-free catalyst that can be used at room temperature without creating toxic by-products. The catalyst is used to create amide bonds, one of the most common chemical components used in the preparation of pharmaceutical compounds. Existing methods often require high temperatures and involve multiple steps and the addition of solvents or other toxic chemicals.
GreenCentre will work with Dr. Hall to scale up the catalyst and use it to make molecules of interest to the pharmaceutical industry, as well as to the agricultural and plastics industries.
“Better amide bond formation has been identified as a key research priority by the pharmaceutical industry, so this technology has the potential to fill an important product development need,” says Lynn Leger, Commercial Development Director at GreenCentre. “It also shows promise as a source of new molecules for use in other industry sectors, so there is a fairly wide scope of potential here.”
The new GreenCentre license agreement was negotiated by TEC Edmonton, a not-for-profit venture between UAlberta and the Edmonton Economic Development Corporation (EEDC) that transforms technologies into business opportunities.
"This is the first UAlberta green technology to be licensed by GreenCentre, marking what we believe is the beginning of a long, prosperous relationship," says Chris Lumb, CEO of TEC Edmonton. "We look forward to this technology benefiting many industries and the environment, while adding to the well-deserved recognition of Canadian green chemistry research."
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Presence of nicotine and antidepressants detected in Antarctic waters - A study with the participation of IDAEA and IGME locates organic contaminants derived from human activity in inland and coastal waters of the frozen continent
Reverse negative impact of ultraviolet radiation on skin
Learning from Nature: How a fungus makes a hard job easier - Researchers analyze a fungal biosynthetic pathway and discover a capable enzyme
Anatomical barriers shield the brain from SARS-CoV-2 invasion at vulnerable interfaces - Absence of evidence for neurotropism and neuroinvasion of several SARS-CoV-2 variants including Omicron
Exposure to air pollution before and after birth may affect fundamental cognitive abilities
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
A clear path to better insights into biomolecules - 3D images with record-breaking resolution
Revolutionizing cancer research with diamonds
Heavy water tastes sweet - But not to mice
Ebola: New studies model a deadly epidemic
